Drugs
Published research on Drugs.

A 2026 two-case report describes teenage girls, 13 and 15, who developed catatonia after corticosteroids for suspected brain inflammation that tests did not confirm. Lorazepam and immune tre…
Read article →
A Norwegian study followed 6,255 young people with ADHD. Clinic-based analysis found no school-grade benefit, despite a tiny link in ordinary regression.
Read article →
In a randomized trial of 111 young adults, one 100-mg dose of amisulpride led to higher blood flow in the ventral striatum than placebo, with or without depression. No other reward region ch…
Read article →
In a survey of 246 Saudi women on adjuvant breast cancer treatment, 54% screened positive for depression and 50% for anxiety; chemotherapy was linked to scores about 9.5 points higher.
Read article →
In a 2026 mouse study, a single 10 mg/kg dose of ketamine reduced swim immobility in stressed mice with the circuit intact (7 mice, P = 0.0093) but did nothing when the thalamic nucleus reun…
Read article →
In 148 stroke patients with depression, slow and normal CYP2C19 metabolizers had similar escitalopram response and remission after 8 weeks. Stroke disability predicted outcomes better than g…
Read article →
In a 2026 study of 40 male rats under 6 weeks of daily restraint stress, 2 weeks of celecoxib improved open-field, maze and swim-test behavior and lowered hippocampal TNF-alpha, IL-1beta, IL…
Read article →